BIOHIT HealthCare is attending BSG LIVE ’22 this June

May 27, 2022

BIOHIT is excited to be exhibiting at the upcoming BSG LIVE ’22 at the ICC in Birmingham. This event, which takes place from the 20th to 23rd of June, showcases the latest clinical and educational developments within gastroenterology and hepatology.

BSG LIVE ’22 will also feature a wide range of national and international speakers, with highlights including a presentation by Dr Cinzia Papadia, Consultant Gastroenterologist at Barts Health NHS Trust. Entitled ‘A new pathway for detection, diagnosis and management of patients at risk of gastric adenocarcinoma’, this fascinating talk will take place on Tuesday the 21st in the Silent Symposium Auditorium, Hall 4. Dr Papadia will be discussing how the Correa’s cascade presents an opportunity for detecting and monitoring precancerous lesions in the gastric mucosa, and will introduce a proposed model for the serological detection of chronic atrophic gastritis to improve case selection for gastroscopy.

Come and speak to the BIOHIT team at stand A56 to learn more about our innovative GastroPanel®, a simple blood test that aids gastric cancer risk stratification. You can also try out the newly launched SmarTest® Calprotectin Home from Preventis, a digital self-testing system that combines a faecal calprotectin test with a smartphone app.

We would love to talk to as many visitors as possible at the event. We look forward to seeing you there!


About BIOHIT HealthCare

BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk

Recent Posts

Exploring the value of biomarkers in gastric cancer screening

October 26, 2023

Stomaching the lack of gastric cancer screening in Europe

October 18, 2023

Why is gastric cancer often diagnosed too late?

October 17, 2023

When should I test for BAD?

September 13, 2023